共 32 条
[1]
Hamed SA(2017)Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications Expert Rev Clin Pharmacol 10 409-428
[2]
Yokomichi H(2017)Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort J Epidemiol 27 S98-s106-986
[3]
Careyva B(2016)Diabetes mellitus: management of gastrointestinal complications Am Fam Phys 94 980-114
[4]
Stello B(2017)Cardiovascular disease Incidence and risk factor patterns among Omanis with type 2 diabetes: a retrospective cohort study Oman Med J 32 106-31
[5]
Al Rawahi AH(2017)Anti-hyperglycemic agents for the treatment of type 2 diabetes mellitus: role in cardioprotection during the last decade Endocr Metab Immune Disord Drug Targets 17 19-18
[6]
Kocyigit D(2013)Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome JAAPA 26 13-1275
[7]
Dickson-Humphries T(2011)Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr 24 1268-894
[8]
Bottenberg B(2014)Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus Am J Cardiol 114 890-558
[9]
Kuntz S(2015)Left ventricular diastolic reserve in patients with type 2 diabetes mellitus Open Heart 2 e000214-1010
[10]
Ernande L(2014)Cost implications of the use of basal insulin glargine in people with early dysglycemia: the ORIGIN trial J Diabetes Complicat 28 553-1573